North America Botulinum Toxin Market Size & Outlook
North America botulinum toxin market, 2018-2030 (US$M)
Related Markets
North America botulinum toxin market highlights
- The North America botulinum toxin market generated a revenue of USD 5,206.4 million in 2023.
- The market is expected to grow at a CAGR of 9.6% from 2024 to 2030.
- In terms of segment, type a was the largest revenue generating product in 2023.
- Type A is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 5,206.4 million |
| Market revenue in 2030 | USD 9,904.7 million |
| Growth rate | 9.6% (CAGR from 2023 to 2030) |
| Largest segment | Type a |
| Fastest growing segment | Type A |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Type A, Type B |
| Key market players worldwide | Ipsen SA, Merz Pharma, US WorldMeds, Galderma Group AG Registered Shares, Evolus Inc, Allergan, Metabiologics, Lanzhou Institute Of Biological Products |
Other key industry trends
- In terms of revenue, North America region accounted for 46.9% of the global botulinum toxin market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 4,199.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Botulinum Toxin Market Scope
Botulinum Toxin Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America botulinum toxin market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to botulinum toxin market will help companies and investors design strategic landscapes.
Type a was the largest segment with a revenue share of 98.94% in 2023. Horizon Databook has segmented the North America botulinum toxin market based on type a, type b covering the revenue growth of each sub-segment from 2018 to 2030.
In 2022, North America accounted for the highest share of 36.8% in terms of revenue of botulinum toxin market. The population aged between 25 and 65 has increased, and this age group is susceptible to skin loosening, wrinkles, dark spots, and other skin conditions.
As a result, there is increased demand for products used to enhance esthetic appeal with increase in the disposable incomes, which is expected to fuel market growth over the forecast period. Moreover, easy availability and increasing adoption of advanced treatment options to enhance one’s esthetic appeal are factors expected to boost market growth.
Reasons to subscribe to North America botulinum toxin market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America botulinum toxin market databook
-
Our clientele includes a mix of botulinum toxin market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America botulinum toxin market , including forecasts for subscribers. This continent databook contains high-level insights into North America botulinum toxin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America botulinum toxin market size, by country, 2018-2030 (US$M)
North America Botulinum Toxin Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
